Everence Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Everence Capital Management’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,698	Closed	-$450K	–	355
2016 Q3	$450K	Hold	5,698	–	–	0.13%	204
2016 Q2	$517K	Hold	5,698	–	–	0.16%	192
2016 Q1	$484K	Hold	5,698	–	–	0.15%	185
2015 Q4	$450K	Hold	5,698	–	–	0.15%	197
2015 Q3	$401K	Hold	5,698	–	–	0.14%	195
2015 Q2	$514K	Hold	5,698	–	–	0.17%	179
2015 Q1	$597K	Hold	5,698	–	–	0.2%	152
2014 Q4	$573K	Buy	5,698 +1,685	+42%	+$168K	0.2%	156
2014 Q3	$384K	Hold	4,013	–	–	0.14%	193
2014 Q2	$374K	Hold	4,013	–	–	0.14%	200
2014 Q1	$334K	Buy	+4,013	New	+$325K	0.13%	206

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Everence Capital Management's MJN Position: Q4 2016 in Review

Everence Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q4 2016, closing a stake of 5,698 shares — an estimated $450K sold.

Everence Capital Management first reported a position in MJN in Q1 2014 and held it in 11 quarters. The position peaked at $597K in Q1 2015. 554 funds tracked by Wall St. Rank hold MJN as of Q4 2016.

Everence Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q4 2016 after selling out during the quarter.
Everence Capital Management sold 5,698 Mead Johnson Nutrition Company shares in Q4 2016, an estimated $450K.
Everence Capital Management first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 11 quarters.
Everence Capital Management's Mead Johnson Nutrition Company position peaked at $597K in Q1 2015.
554 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2016.

Based on Everence Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.